Implementing Photodissociation Mass Spectrometry to study Disease and Lipid Structure
利用光解离质谱研究疾病和脂质结构
基本信息
- 批准号:10377907
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-10 至 2022-06-01
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAffectBiologicalBiological MarkersCancerousCardiolipinsCardiovascular DiseasesCell physiologyCellsCellular MembraneCollaborationsComplexCoupledDevelopmentDiabetes MellitusDiseaseDissociationFatty AcidsGlycerophospholipidsHormone ReceptorImaging TechniquesInner mitochondrial membraneIonsIsomerismLasersLipidsLocationMalignant NeoplasmsMammary NeoplasmsMass Spectrum AnalysisMembraneMetabolicMethodsMitochondriaNerve DegenerationNucleotidesPathway interactionsPhospholipidsPhysiologic pulsePositioning AttributeProgesterone Receptor StatusPrognostic MarkerProteinsReportingRespiratory ProcessRoleSamplingSignal PathwaySignal TransductionSpecificityStructureTechniquesTissuesTumor SubtypeTumor TissueWorkanticancer researchcancer cellcancer subtypescohortdiagnostic biomarkerdiagnostic toolexperimental studyhigh throughput analysisinsightlipid metabolismlipid structurelipidomicsmalignant breast neoplasmnew therapeutic targetpi bondpotential biomarkerprotein functionprotein structurespecific biomarkersstereochemistrysuccesstandem mass spectrometrytheoriestherapeutic targettooltumortumorigenesisultraviolet
项目摘要
Abstract
Lipids fulfill an array of cellular functions by composing cellular membranes, engaging in signaling pathways,
and modulating protein structure. Disruptions in carefully regulated lipid compositions perturb cellular function
and correlate with cancer, neurodegeneration, diabetes, and cardiovascular disease. The correlation between
aberrant lipid composition and disease has inspired lipid profiling as a powerful diagnostic tool. Analysis of
structural changes that concur with disease promises to reveal highly specific biomarkers and insight into the
disease development. This proposal focuses on the development of ultraviolet photodissociation (UVPD) tandem
mass spectrometry approaches for the characterization of glycerophospholipids (GPL) and the cardiolipin (CL)
subtype in cancerous tissue. Cancer induces a stark metabolic shift that significantly affects lipid metabolism.
UVPD is a high-energy ion activation technique used for MS/MS analysis, informing subtle features that are not
captured by other mass spectrometry methods. Implementing UVPD to track changes in tumorous GPL
structures with fine detail offers an avenue to explore the full effects of cancer on lipid dysregulation. The
objectives of this proposal include: Aim 1: Development of an LC-MS-UVPD workflow to identify changes in
phospholipid structure between breast cancer tissue subtypes. A quantitative lipidomic workflow incorporating
UVPD will be developed for the high-throughput analysis of GPL isomers. The proposed strategy will be applied
to analyze a cohort of breast tumor lipid extracts and identify significant structural changes and prognostic
biomarkers. Aim 2: Complete characterization of cardiolipins from cancer cells using UVPD. CLs are of particular
relevance for cancer research but present challenging structures. UVPD is the only activation method reported
to provide detailed CL characterization and will be expanded upon to characterize CLs from tumorous tissue. All
together, the proposed strategies promise avenues to identify diagnostic biomarkers, potential therapeutic
targets, and disease mechanisms. Importantly, these strategies would be applicable for lipidomic analyses of
GPLs and CLs from other diseases.
摘要
脂质通过组成细胞膜,参与信号通路,
和调节蛋白质结构。仔细调节的脂质组成的破坏扰乱细胞功能
并与癌症、神经退化、糖尿病和心血管疾病相关。的相关性
异常的脂质组成和疾病激发了脂质谱分析作为一种强大的诊断工具。分析
与疾病同时发生的结构变化有望揭示高度特异性的生物标志物,并深入了解
疾病发展。本论文主要研究紫外光解离(UVPD)串联技术
用于表征甘油磷脂(GPL)和心磷脂(CL)的质谱法
癌组织中的亚型。癌症引起显著影响脂质代谢的明显代谢转变。
UVPD是一种用于MS/MS分析的高能离子活化技术,可提供不需要的细微特征。
通过其他质谱方法捕获。实施UVPD以跟踪肿瘤GPL的变化
具有精细细节的结构提供了一种探索癌症对脂质失调的全面影响的途径。的
该提案的目标包括:目标1:开发LC-MS-UVPD工作流程,以确定
乳腺癌组织亚型之间的磷脂结构。一种定量脂质组学工作流程,
UVPD将被开发用于GPL异构体的高通量分析。拟议战略将适用于
分析一组乳腺肿瘤脂质提取物,并确定显著的结构变化和预后
生物标志物。目的2:使用UVPD完全表征来自癌细胞的心磷脂。CL特别是
与癌症研究相关,但目前具有挑战性的结构。UVPD是唯一报道的活化方法
以提供详细的CL表征,并将扩展到表征来自肿瘤组织的CL。所有
总而言之,所提出的策略为识别诊断生物标志物、潜在的治疗方法提供了途径
目标和疾病机制。重要的是,这些策略将适用于脂质组学分析,
其他疾病的GPL和CL。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhanced Characterization of Cardiolipins via Hybrid 193 nm Ultraviolet Photodissociation Mass Spectrometry.
通过杂交193 nm紫外线光解离质谱法增强了心磷脂的表征。
- DOI:10.1021/acs.analchem.1c05071
- 发表时间:2022-02-22
- 期刊:
- 影响因子:7.4
- 作者:Macias, Luis A.;Brodbelt, Jennifer S.
- 通讯作者:Brodbelt, Jennifer S.
Relative Quantitation of Unsaturated Phosphatidylcholines Using 193 nm Ultraviolet Photodissociation Parallel Reaction Monitoring Mass Spectrometry.
- DOI:10.1021/jacs.1c05295
- 发表时间:2021-09-15
- 期刊:
- 影响因子:15
- 作者:Macias LA;Garza KY;Feider CL;Eberlin LS;Brodbelt JS
- 通讯作者:Brodbelt JS
Influence of Primary Structure on Fragmentation of Native-Like Proteins by Ultraviolet Photodissociation.
- DOI:10.1021/jasms.1c00269
- 发表时间:2021-12-01
- 期刊:
- 影响因子:3.2
- 作者:Macias LA;Sipe SN;Santos IC;Bashyal A;Mehaffey MR;Brodbelt JS
- 通讯作者:Brodbelt JS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis A Macias其他文献
Luis A Macias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别: